Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases

Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases

US Patent 12496296 · Granted Dec 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2024
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2024
Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and t2024
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolas2022
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2021
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2021
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2020
Dosing regimen for treatment of cognitive and motor impairments with blood plasm2019